Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
Biotheus, Hansoh Expand Partnership in $694M ADC Deal
BioSpace
Sun, 03/17/24 - 09:20 pm
Biotheus
Hansoh
antibody-drug conjugate
oncology
inflammatory diseases
ADC Biotech Tubulis Closes Upsized $138M Financing Round
BioSpace
Thu, 03/14/24 - 06:16 pm
Tubulis
funding
antibody-drug conjugate
GSK Advances Blenrep’s Potential Comeback with Second Phase III Win
BioSpace
Thu, 03/7/24 - 05:32 pm
GSK
Blenrep
antibody-drug conjugate
clinial trials
Zymeworks halts plans for phase 2 ADC trial to mull 'evolving clinical landscape'
Fierce Biotech
Thu, 03/7/24 - 11:37 am
antibody-drug conjugate
clinical trials
Zymeworks
zanidatamab
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
oncology
cancer
antibody-drug conjugate
Merck
AbbVie
Pfizer
AstraZeneca
Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030
Fierce Pharma
Thu, 02/29/24 - 07:05 pm
Pfizer
oncology
Pharma CEOs
Albert Bourla
antibody-drug conjugate
ProfoundBio secures $112m to advance ADC portfolio for cancer
Pharmaceutical Business Review
Wed, 02/14/24 - 10:52 am
ProfoundBio
funding
cancer
antibody-drug conjugate
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff
Fierce Pharma
Mon, 01/22/24 - 11:21 am
Gilead Sciences
antibody-drug conjugate
Trodelvy
lung cancer
clinical trials
LegoChem, riding ADC sugar rush, raises $411M from confectionery company
Fierce Biotech
Tue, 01/16/24 - 09:37 am
LegoChem Biosciences
JNJ
antibody-drug conjugate
JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals
Fierce Pharma
Thu, 01/11/24 - 11:34 am
Pfizer
oncology
cancer
antibody-drug conjugate
JPMHC 2024
J&J to acquire ADC drug developer Ambrx for $2B
BioPharma Dive
Mon, 01/8/24 - 11:35 am
JNJ
Ambrx
M&A
antibody-drug conjugate
JPMHC 2024
JPM24 opens with ADCs the hottest ticket in San Francisco
Fierce Biotech
Mon, 01/8/24 - 11:21 am
JPMHC 2024
antibody-drug conjugate
venture capital
Roche Signs Potential $1B ADC Cancer Deal with China’s MediLink
BioSpace
Wed, 01/3/24 - 09:36 am
Roche
MediLink Therapeutics
oncology
antibody-drug conjugate
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
AbbVie
Immunogen
M&A
antibody-drug conjugate
Sanofi’s oncology strategy suffers another blow as ADC scrapped over phase 3 lung cancer fail
Fierce Biotech
Thu, 12/21/23 - 09:40 am
Sanofi
antibody-drug conjugate
lung cancer
clinical trials
tusamitamab ravtansine
Immunogen
GSK heads back to Hansoh, paying $185M upfront for another ADC
Fierce Biotech
Wed, 12/20/23 - 09:46 am
GSK
Hansoh Pharmaceutical
antibody-drug conjugate
Bristol Myers pays SystImmune $800M and adds to pharma’s ‘ADC’ deal spree
BioPharma Dive
Tue, 12/12/23 - 09:58 am
Bristol Myers Squibb
SystImmune
antibody-drug conjugate
cancer
ADC and GLP-1 Rocket Ride Continues as 2023 Comes to Close
BioSpace
Sun, 12/3/23 - 09:34 pm
antibody-drug conjugate
GLP-1 agonist
AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval
BioSpace
Fri, 12/1/23 - 11:23 am
AbbVie
Teliso-V
antibody-drug conjugate
non-small cell lung cancer
Pages
1
2
3
4
5
6
7
8
9
next ›
last »